GO:0004751 ribose-5-phosphate isomerase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004751 ribose-5-phosphate isomerase activity catalyzes the reversible interconversion of aldehydo-D-ribose 5-phosphate and D-ribulose 5-phosphate, a central step in the pentose phosphate pathway.
• Two structurally unrelated enzyme families, RPI A (Ribose-5-phosphate isomerase A) and RPI B (Ribose-5-phosphate isomerase B), carry out this activity in different organisms.
• In humans, RPIA (ribose-5-phosphate isomerase A) supports nucleotide biosynthesis and has been implicated in colorectal cancer, lung cancer, and hepatocellular carcinoma.
• RPIA is post-translationally regulated by arginine methylation, which senses glucose availability and promotes cancer cell survival.
• In model organisms, reduced RPIA-1 expression in specific neurons extends lifespan in Caenorhabditis elegans, linking this metabolic activity to aging.
• RPI B is a validated drug target in Trypanosoma brucei and Leishmania infantum, and is also used biotechnologically for D-allose production.
Description
Ribose-5-phosphate isomerase activity (GO:0004751) is a molecular function that catalyzes the reversible isomerization of aldehydo-D-ribose 5-phosphate to D-ribulose 5-phosphate. This reaction sits at a key branch point of the pentose phosphate pathway, balancing the production of ribose 5-phosphate for nucleotide and nucleic acid synthesis against the generation of ribulose 5-phosphate for the non-oxidative arm of the pathway. Because rapidly dividing cells require abundant nucleotides, this activity is essential for cell proliferation and is therefore of broad interest in cancer biology, infectious disease, and metabolic engineering. The enzymes that carry out GO:0004751 fall into two evolutionarily distinct families: RPI A and RPI B. RPI A enzymes are found in many bacteria, plants, and animals, including humans, while RPI B enzymes are present in some bacteria, protozoan parasites, and certain fungi. Despite catalyzing the same reaction, these families differ in sequence, structure, and catalytic mechanism, which has implications for drug design and for understanding metabolic adaptation in different organisms. In humans, the RPI A enzyme encoded by RPIA has been linked to colorectal cancer survival, lung cancer cell death, and hepatocarcinogenesis through signaling pathways involving PP2A and ERK. In the parasite Trypanosoma brucei, knockdown of RPI B compromises bloodstream form infectivity, and Leishmania infantum RPI B is being explored as a drug target. These findings highlight GO:0004751 as both a fundamental metabolic activity and a potential therapeutic node.
ribose-5-phosphate isomerase activity At A Glance
| GO ID | GO:0004751 |
|---|---|
| GO term | ribose-5-phosphate isomerase activity |
| Ontology | molecular_function |
| Definition | Catalysis of the reaction: aldehdyo-D-ribose 5-phosphate = D-ribulose 5-phosphate. |
| Synonym | 5-phosphoribose isomerase activity; D-ribose-5-phosphate aldose-ketose-isomerase activity; D-ribose 5-phosphate isomerase activity; D-ribose-5-phosphate ketol-isomerase activity; pentose phosphate isomerase (PPI); phosphopentoseisomerase activity; phosphopentosisomerase activity; phosphoriboisomerase activity; ribose 5-phosphate epimerase activity; ribose phosphate isomerase activity |
| Major function | Reversible isomerization of ribose 5-phosphate to ribulose 5-phosphate in the pentose phosphate pathway |
| Enzyme families | RPI A and RPI B, which are structurally unrelated |
| Human gene | RPIA encodes ribose-5-phosphate isomerase A |
| Pathway context | Pentose phosphate pathway, non-oxidative branch |
| Disease relevance | Cancer (colorectal, lung, liver), parasite infectivity |
What Is GO:0004751?
GO:0004751 ribose-5-phosphate isomerase activity is defined by the Gene Ontology as the catalysis of the reaction: aldehydo-D-ribose 5-phosphate = D-ribulose 5-phosphate. In other words, it is the enzyme activity that reversibly converts ribose 5-phosphate into its ketose isomer, ribulose 5-phosphate, without adding or removing any atoms. This isomerization is a core reaction of the pentose phosphate pathway and is carried out by enzymes known as ribose-5-phosphate isomerases, which belong to the RPI A and RPI B families.
Why Is ribose-5-phosphate isomerase activity Important in Cell Biology?
GO:0004751 ribose-5-phosphate isomerase activity is important because it controls the flux between ribose 5-phosphate, which is needed for nucleotide and nucleic acid synthesis, and ribulose 5-phosphate, which feeds into the non-oxidative pentose phosphate pathway. This balance is critical for proliferating cells, and its dysregulation has been linked to cancer progression and to the survival of intracellular parasites. Beyond medicine, the activity is exploited in biotechnology for the production of rare sugars such as D-allose.
• Provides ribose 5-phosphate for nucleotide biosynthesis, supporting DNA and RNA synthesis in dividing cells.
• Connects the oxidative and non-oxidative branches of the pentose phosphate pathway.
• Supports cancer cell survival and proliferation in colorectal cancer, lung cancer, and hepatocellular carcinoma.
• Is post-translationally regulated by arginine methylation in response to glucose availability.
• Is essential for Trypanosoma brucei bloodstream form infectivity.
• Is a candidate drug target in Leishmania infantum.
• Is used in biotechnological production of D-allose.
• Modulates lifespan in Caenorhabditis elegans when reduced in specific neurons.
• Represents a metabolic vulnerability that can be explored with CRISPR knockout models.
• Has two structurally distinct enzyme families (RPI A and RPI B) that offer different drug design opportunities.
Molecular Mechanism of ribose-5-phosphate isomerase activity
Substrate binding and isomerization
In simple terms: The enzyme grabs ribose 5-phosphate and rearranges it into a slightly different sugar, ribulose 5-phosphate.
Ribose-5-phosphate isomerase binds the open-chain form of aldehydo-D-ribose 5-phosphate and catalyzes its reversible isomerization to D-ribulose 5-phosphate. This reaction proceeds through an enediolate intermediate and does not require cofactors such as NAD+ or ATP. The equilibrium favors ribulose 5-phosphate under standard conditions, but the reaction direction in cells depends on metabolic demand.
Two distinct enzyme families: RPI A and RPI B
In simple terms: There are two completely different protein machines that can do this same job.
RPI A and RPI B are structurally unrelated and use different catalytic strategies, yet both catalyze the same overall reaction. RPI A enzymes are found in many organisms including humans, while RPI B enzymes are present in some bacteria and protozoan parasites such as Trypanosoma brucei and Leishmania infantum. This structural divergence makes RPI B an attractive selective drug target because inhibiting it may not affect the human RPI A enzyme.
Role in the pentose phosphate pathway
In simple terms: This reaction is a key intersection in a metabolic highway that makes building blocks for DNA and RNA.
In the non-oxidative branch of the pentose phosphate pathway, ribose-5-phosphate isomerase activity interconverts ribose 5-phosphate and ribulose 5-phosphate, which can then be converted to xylulose 5-phosphate and other intermediates. This allows cells to balance the production of ribose 5-phosphate for nucleotide synthesis with the generation of reducing power and glycolytic intermediates. The activity is therefore central to metabolic flexibility in proliferating cells.
Post-translational regulation by arginine methylation
In simple terms: A chemical tag on the enzyme helps it respond to sugar levels and keep cancer cells alive.
In human colorectal cancer cells, RPIA is modified by arginine methylation, which senses glucose availability and promotes cell survival. This methylation event regulates RPIA function and links glucose metabolism to nucleotide biosynthesis, providing a mechanism by which cancer cells adapt to metabolic stress. This regulation is an example of how GO:0004751 activity is tuned post-translationally rather than simply by changes in enzyme abundance.
Catalytic mechanism and structural features
In simple terms: The enzyme uses specific amino acids in its active site to shuffle atoms around.
RPI A enzymes typically use a conserved active site with acidic and basic residues that stabilize the enediolate intermediate during isomerization. RPI B enzymes use a different set of catalytic residues and a distinct overall fold, reflecting convergent evolution. Detailed structural and kinetic studies of both families have been reviewed, providing a framework for understanding substrate specificity and for designing inhibitors.
Key Genes Involved in GO:0004751 ribose-5-phosphate isomerase activity
The following genes and proteins are directly associated with ribose-5-phosphate isomerase activity (GO:0004751) or its regulation in humans, parasites, and model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RPIA | Encodes human ribose-5-phosphate isomerase A, catalyzing the interconversion of ribose 5-phosphate and ribulose 5-phosphate | Implicated in colorectal cancer, lung cancer, and hepatocellular carcinoma; regulated by arginine methylation |
| RPIB (TbRPI-B) | Trypanosoma brucei ribose-5-phosphate isomerase B | Knockdown compromises bloodstream form infectivity; potential drug target |
| LiRPI-B | Leishmania infantum ribose-5-phosphate isomerase B | Validated as a potential drug target for leishmaniasis |
| CfRPI-B | Curtobacterium flaccumfaciens ribose-5-phosphate isomerase B | Used for biotechnological production of D-allose |
| RPIA-1 (C. elegans) | Caenorhabditis elegans ortholog of ribose-5-phosphate isomerase A | Reduced expression in specific neurons promotes longevity |
| PP2A | Protein phosphatase 2A, a signaling regulator | Mediates RPIA effects on hepatocarcinogenesis through ERK signaling |
| ERK | Extracellular signal-regulated kinase | Downstream effector in RPIA-regulated hepatocarcinogenesis |
| PRMT (arginine methyltransferase) | Enzyme that methylates RPIA | Senses glucose to promote colorectal cancer cell survival |
| RPE | Ribulose-5-phosphate 3-epimerase, adjacent pentose phosphate pathway enzyme | Context for pathway flux |
| TKT | Transketolase, pentose phosphate pathway enzyme | Works with RPI in non-oxidative branch |
| G6PD | Glucose-6-phosphate dehydrogenase, oxidative branch enzyme | Provides NADPH and links to RPI activity |
| PGLS | 6-phosphogluconolactonase | Pentose phosphate pathway component |
| 6PGD | 6-phosphogluconate dehydrogenase | Oxidative branch enzyme |
| PRPS1 | Phosphoribosyl pyrophosphate synthetase 1 | Uses ribose 5-phosphate downstream of RPI |
| RBKS | Ribokinase | Phosphorylates ribose to ribose 5-phosphate, feeding RPI |
| TALDO1 | Transaldolase 1 | Non-oxidative pentose phosphate pathway enzyme |
| SLC (glucose transporters) | Glucose uptake | Affects substrate availability for RPI |
| HIF-1alpha | Hypoxia-inducible factor | May influence metabolic flux through pentose phosphate pathway |
How Is ribose-5-phosphate isomerase activity Regulated?
Ribose-5-phosphate isomerase activity is regulated at multiple levels. In human colorectal cancer cells, RPIA is post-translationally modified by arginine methylation, which senses glucose availability and promotes cell survival. This methylation is mediated by protein arginine methyltransferases and provides a direct link between nutrient status and pentose phosphate pathway flux. In hepatocarcinogenesis, RPIA regulates signaling through PP2A and ERK, suggesting that its expression or activity can influence downstream kinase cascades. Additionally, reduced RPIA-1 expression in specific neurons of Caenorhabditis elegans extends lifespan, indicating that regulation of this activity in specific tissues can affect organismal aging. At the transcriptional level, RPIA expression may be influenced by oncogenic and metabolic transcription factors, though specific mechanisms are still being elucidated.
ribose-5-phosphate isomerase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RPIA | Colorectal cancer | HCT116 or SW480 knockout/overexpression models |
| RPIA | Lung cancer | A549 or H1299 knockout models to study ROS, autophagy, apoptosis |
| RPIA | Hepatocellular carcinoma | HepG2 or Huh7 knockout models to study PP2A/ERK signaling |
| TbRPI-B | Trypanosoma brucei infectivity | Parasite knockdown and mouse infection models |
| LiRPI-B | Leishmania infantum infection | Enzyme inhibition assays and macrophage infection models |
Cancer
RPIA, the human enzyme carrying GO:0004751 activity, is implicated in multiple cancers. In colorectal cancer, arginine methylation of RPIA senses glucose and promotes cell survival, linking metabolic status to tumor growth. In lung cancer, suppression of RPIA induces reactive oxygen species, activating autophagy, apoptosis, and cellular senescence. In hepatocellular carcinoma, RPIA regulates hepatocarcinogenesis via PP2A and ERK signaling, suggesting that its inhibition could reduce tumor progression. These findings position ribose-5-phosphate isomerase activity as a potential therapeutic target in oncology.
Parasitic infections
Ribose-5-phosphate isomerase B is essential for the infectivity of Trypanosoma brucei, the causative agent of African sleeping sickness; knockdown of the enzyme compromises bloodstream form infectivity. In Leishmania infantum, RPI B has been chemically validated as a drug target, with inhibitors showing potential for treating leishmaniasis. Because RPI B is structurally distinct from human RPI A, selective inhibition may be achievable with fewer side effects.
Aging and neurodegeneration
In Caenorhabditis elegans, reduced expression of RPIA-1 in specific neurons and at specific time points promotes longevity, suggesting that modulating this metabolic activity can influence aging. While direct links to human neurodegeneration are not yet established, the conserved role of the pentose phosphate pathway in neuronal redox balance makes this an area of active investigation.
From ribose-5-phosphate isomerase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of RPIA reduce cancer cell proliferation? | RPIA knockout in colorectal or lung cancer cell lines |
| Does RPIA arginine methylation affect glucose sensing? | Point mutation of methylation sites in RPIA followed by glucose starvation |
| Can RPI B be selectively inhibited without affecting human RPI A? | Knock-in of parasite RPI B into human cells or in vitro enzyme assays |
| Does RPIA overexpression promote hepatocarcinogenesis? | RPIA overexpression in hepatoma cell lines and mouse xenografts |
| Does neuronal RPIA-1 reduction extend lifespan? | Tissue-specific knockdown or knockout in C. elegans |
| Can RPI B be engineered for D-allose production? | Overexpression of bacterial RPI B in industrial strains |
How to Study the ribose-5-phosphate isomerase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled enzymatic assay | Ribose-5-phosphate isomerase activity | Kinetic characterization of recombinant enzymes |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying metabolic vulnerabilities in cancer cells |
| Metabolomics (LC-MS) | Levels of pentose phosphate pathway intermediates | Assessing metabolic impact of RPI modulation |
| Isotope tracing | Flux through pentose phosphate pathway | Determining pathway direction and compensation |
| X-ray crystallography | Three-dimensional protein structure | Structure-guided inhibitor design |
| Western blot | Protein expression and post-translational modifications | Detecting RPIA arginine methylation |
| RNA-seq | Transcriptional changes | Identifying pathways affected by RPI loss |
| Mouse xenograft | Tumor growth in vivo | Testing RPIA as a therapeutic target |
Enzymatic activity assays
Ribose-5-phosphate isomerase activity can be measured spectrophotometrically by coupling the formation of ribulose 5-phosphate to NADH oxidation via ribulose-5-phosphate 3-epimerase and other enzymes, or by colorimetric assays that detect ketose sugars. These assays are used to characterize recombinant RPI A and RPI B enzymes, determine kinetic parameters, and screen for inhibitors.
CRISPR-based genetic screens
Genome-wide CRISPR knockout screens can identify genes that are essential in specific metabolic contexts, including those involved in the pentose phosphate pathway. Such screens have the potential to reveal synthetic lethal interactions with RPIA loss, guiding combination therapies.
Metabolomics and flux analysis
Mass spectrometry-based metabolomics can quantify ribose 5-phosphate, ribulose 5-phosphate, and other pentose phosphate pathway intermediates in cells with modified RPI activity. Isotope tracing can further define flux through the pathway and reveal compensatory mechanisms.
Structural biology and inhibitor design
X-ray crystallography and NMR spectroscopy have been used to solve structures of RPI A and RPI B enzymes, revealing distinct active site architectures. These structures guide the design of small-molecule inhibitors, particularly for parasite RPI B.
How CRISPR Can Be Used to Study GO:0004751 ribose-5-phosphate isomerase activity
Knockout
CRISPR knockout of RPIA in human cancer cell lines such as HCT116, A549, or HepG2 can be used to study the consequences of losing ribose-5-phosphate isomerase activity on proliferation, apoptosis, and metabolic flux. Knockout models are also valuable for validating drug targets in parasites, although CRISPR systems for Trypanosoma and Leishmania are less developed.
Point Mutation
Point mutations can be introduced into RPIA to ablate specific post-translational modification sites, such as arginine residues targeted by methylation, to test their role in glucose sensing and cancer cell survival. Catalytic dead mutants can also be generated to separate enzymatic activity from potential non-catalytic functions.
Knock-in
Knock-in of tagged RPIA (e.g., FLAG, HA, or GFP) allows for affinity purification, localization studies, and interaction proteomics. Knock-in of parasite RPI B into model organisms or human cells can facilitate drug screening and target validation.
Overexpression
Overexpression of RPIA or RPI B can be achieved by lentiviral transduction or CRISPR activation. Overexpression models are useful for studying oncogenic potential, as shown for RPIA in hepatocarcinogenesis, and for biotechnological applications such as D-allose production.
How EDITGENE Supports ribose-5-phosphate isomerase activity Research
Researchers studying ribose-5-phosphate isomerase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell survival, parasite infectivity, or metabolic adaptation. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that enable such causal inferences.
Contact EDITGENE today to design your custom CRISPR model for ribose-5-phosphate isomerase activity research.
Frequently Asked Questions About ribose-5-phosphate isomerase activity
What is ribose-5-phosphate isomerase activity?
Ribose-5-phosphate isomerase activity (GO:0004751) is the enzyme activity that catalyzes the reversible conversion of aldehydo-D-ribose 5-phosphate to D-ribulose 5-phosphate, a key step in the pentose phosphate pathway.
What genes are involved in ribose-5-phosphate isomerase activity?
In humans, the RPIA gene encodes ribose-5-phosphate isomerase A. In parasites, RPI B is encoded by genes such as TbRPI-B in Trypanosoma brucei and LiRPI-B in Leishmania infantum.
What is the difference between RPI A and RPI B?
RPI A and RPI B are structurally unrelated enzyme families that catalyze the same reaction. RPI A is found in humans and many other organisms, while RPI B is present in some bacteria and protozoan parasites.
How is ribose-5-phosphate isomerase activity regulated?
RPIA can be regulated by arginine methylation in response to glucose levels, and its expression influences signaling pathways such as PP2A and ERK in liver cancer.
What diseases are associated with ribose-5-phosphate isomerase activity?
Altered RPIA activity has been implicated in colorectal cancer, lung cancer, and hepatocellular carcinoma. Parasite RPI B is essential for Trypanosoma brucei infectivity and is a drug target in Leishmania infantum.
How can I study ribose-5-phosphate isomerase activity in the lab?
Common methods include coupled enzymatic assays, CRISPR knockout or overexpression in cell lines, metabolomics, and structural biology approaches.
Is ribose-5-phosphate isomerase a good drug target?
RPI B from parasites is considered a promising drug target because it is structurally distinct from human RPI A, allowing for selective inhibition.
What is the role of RPIA in cancer?
RPIA supports nucleotide synthesis and cancer cell survival. Its suppression can induce ROS, autophagy, apoptosis, and senescence in lung cancer, and it regulates hepatocarcinogenesis via PP2A and ERK.
Can ribose-5-phosphate isomerase activity be used in biotechnology?
Yes, RPI B enzymes are used for the production of rare sugars such as D-allose.
Does ribose-5-phosphate isomerase activity affect aging?
In Caenorhabditis elegans, reduced expression of RPIA-1 in specific neurons promotes longevity, suggesting a link between this activity and aging.
Conclusion
Ribose-5-phosphate isomerase activity (GO:0004751) is a fundamental metabolic function that bridges nucleotide biosynthesis and the pentose phosphate pathway. Its two enzyme families, RPI A and RPI B, play critical roles in human cancer, parasite infectivity, and organismal aging. Understanding its regulation and developing tools to manipulate it are essential for both basic research and therapeutic development. EDITGENE provides the CRISPR models and bioinformatics support needed to study this activity in any biological context.
References
- 1. Shen WC et al.. 2023. Reduced Ribose-5-Phosphate Isomerase A-1 Expression in Specific Neurons and Time Points Promotes Longevity in Caenorhabditis elegans.. Antioxidants (Basel) 12(1) PMID: 36670987
- 2. Loureiro I et al.. 2015. Ribose 5-phosphate isomerase B knockdown compromises Trypanosoma brucei bloodstream form infectivity.. PLoS Negl Trop Dis 9(1):e3430 PMID: 25568941
- 3. Guo J et al.. 2020. Arginine methylation of ribose-5-phosphate isomerase A senses glucose to promote human colorectal cancer cell survival.. Sci China Life Sci 63(9):1394-1405 PMID: 32157557
- 4. Chen J et al.. 2020. Ribose-5-phosphate isomerases: characteristics, structural features, and applications.. Appl Microbiol Biotechnol 104(15):6429-6441 PMID: 32533303
- 5. Zheng Q et al.. 2024. Characterization of a novel ribose-5-phosphate isomerase B from Curtobacterium flaccumfaciens ZXL1 for D-allose production.. Food Sci Biotechnol 33(7):1641-1649 PMID: 38623425
- 6. Nieh YC et al.. 2022. Suppression of Ribose-5-Phosphate Isomerase a Induces ROS to Activate Autophagy, Apoptosis, and Cellular Senescence in Lung Cancer.. Int J Mol Sci 23(14) PMID: 35887232
- 7. Dickie EA et al.. 2021. Toward Chemical Validation of Leishmania infantum Ribose 5-Phosphate Isomerase as a Drug Target.. Antimicrob Agents Chemother 65(7):e0189220 PMID: 33875438
- 8. Ciou SC et al.. 2015. Ribose-5-phosphate isomerase A regulates hepatocarcinogenesis via PP2A and ERK signaling.. Int J Cancer 137(1):104-15 PMID: 25429733
